Oxybutynin Extended-Release Tablets and Refissa Topical
Determining the interaction of Oxybutynin Extended-Release Tablets and Refissa Topical and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: oxybutynin
Brand name: Ditropan XL, Anturol, Gelnique, Oxytrol
Synonyms: Oxybutynin
Generic Name: tretinoin topical
Brand name: Altreno, Atralin, Avita, Refissa, Renova, Retin-A, Tretinoin Emollient Topical, Retin A Micro Gel, Retisol-A, Stie Vaa, Stie Vaa Forte, Stievaa, Vitinoin, Altinac, Tretin-X, Retin A Micro Gel Pump, Renova Pump, Retin-A Micro Microsphere Pump, Tretinoin Microsphere
Synonyms: Refissa
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Oxybutynin Extended-Release Tablets-Refludan
- Oxybutynin Extended-Release Tablets-Regadenoson
- Oxybutynin Extended-Release Tablets-Regadenoson Intravenous
- Oxybutynin Extended-Release Tablets-Regenecare HA
- Oxybutynin Extended-Release Tablets-Regenecare HA Spray
- Oxybutynin Extended-Release Tablets-Regimex
- Refissa Topical-Oxybutynin Gel
- Refissa Topical-Oxybutynin Oral Solution
- Refissa Topical-Oxybutynin Syrup
- Refissa Topical-Oxybutynin Tablets
- Refissa Topical-Oxybutynin transdermal
- Refissa Topical-Oxybutynin Transdermal System